Shares in Sanofi have come under pressure as it reported the results of a trial of atopic dermatitis (AD) candidate amlitelimab that met all objectives – but seem to have disappointed investors. The ...
Native Tucsonan Lucas Irons lived day by day; he never thought too far ahead. But early last week, the 26-year-old orthopedic nurse living in Everett, Wash., broke pattern. In a telephone call with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback